Stock listing

SDZ Stock Price, News, Filings & Events — Sandoz Group Ltd

Selected listing: SDZ · VIE · EUR · AT

This page tracks Sandoz Group Ltd's SDZ:VIE listing on VIE in EUR for AT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SDZ:VIE. SDZ:VIE is the stock-level entry point for investors researching Sandoz Group Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sandoz Group Ltd, traded under the ticker SDZ, is a public company based in Switzerland. The company has a market capitalization of approximately 34.7 billion Swiss francs. Sandoz specializes in generic pharmaceuticals and biosimilars, contributing to the healthcare sector by providing accessible medication options.

SDZ:VIEEURATUpdated September 18, 2026
Sandoz Group Ltd logo
Ticker
SDZ:VIE
Asset type
Stock
Market cap
$36.21B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
VIE
Currency
EUR

Sandoz Group Ltd SDZ:VIE stock context

This page tracks Sandoz Group Ltd's SDZ:VIE listing on VIE in EUR for AT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SDZ:VIE. SDZ:VIE is the stock-level entry point for investors researching Sandoz Group Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Sandoz Group Ltd, traded under the ticker SDZ, is a public company based in Switzerland. The company has a market capitalization of approximately 34.7 billion Swiss francs. Sandoz specializes in generic pharmaceuticals and biosimilars, contributing to the healthcare sector by providing accessible medication options.

Latest news from Sandoz Group Ltd

All Sandoz Group Ltd news →

Sandoz Group Ltd earnings calls

Research Sandoz Group Ltd

Alternate listings